Law

Yesterday DDLaw subscribers heard about the big CA Supreme Court appeal grant on innovator (Conte) liability before anybody else on the Internet.  If that kind of thing is important to you or your company, be sure to re-subscribe to stay in the know.

That's right - the California Supreme Court recently granted an appeal in T.H. v. Novartis Pharmaceuticals Corp., an even more extreme Conte follow-on that imposed innovator liability in perpetuity − for injuries occurring even after an innovator manufacturer had sold all rights and left the relevant market altogether.  We shared the news yesterday on the Drug and Device Law blog's new home and through a breaking news e-mail to our readers who re-subscribed through our new site.   Once again we were first on the web with important drug/device product liability news.

Unfortunately, if you didn't re-subscribe, we weren't able to include you on our breaking news e-mail. Due to laws governing e-mail, once we moved the blog to its new site, we could only send our new posts via e-mail to people who subscribed on the new site.

So that we can keep you up-to-date on the drug and device product liability cases around the country that could affect you, please take a couple seconds (if you haven't already) to complete the subscription form for the new site. (You will have to confirm your subscription by clicking a link in an e-mail we send you.) It's quick and easy and allows us to share ground-breaking news – like the California Supreme Court's decision to review innovator liability – with you!

Remember, a defense win anywhere helps defendants everywhere.  That's our motto.  That's why we do what we do.

- Bexis